The SEC has halted trading in SCWorx (WORX) in apparent response to concerns over its previously announced multimillion-test order for COVID-19 blood tests.
On April 13, the company announced that
it received an order for 2M tests from virtual healthcare network
Rethink My Healthcare with a provision for additional orders for 2M
tests per week for 23 weeks, an order it confirmed on April 17 after short seller Hindenburg Research published a report questioning its veracity.
https://seekingalpha.com/news/3563088-sec-suspends-trading-in-scworx-over-covidminus-19-test-issue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.